Screening plus equitable provision of vitamin D supplements could mitigate many adverse outcomes
For nothing worthy proving can be proven,
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
I have received two research grants, one from sanofi-aventis, who market cholecalciferol in Australia, and one from DiaSorin in the US, who manufacture an assay for measurement of serum 25(OH)D. In addition, I am speaking at meetings for sanofi-aventis and DiaSorin later this year.